Your search returned 719 results.

Results
	321.	Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts. [electronic resource] by Gurtner, Kristin Ebert, Nadja Pfitzmann, Dorothee Eicheler, Wolfgang Zips, Daniel Baumann, Michael Krause, Mechthild Producer: 20151028 In: Radiation oncology (London, England) vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	322.	[About new treatments in thoracic oncology]. [electronic resource] by Couraud, S Producer: 20131118 In: Revue de pneumologie clinique vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	323.	Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN). [electronic resource] by Machiels, J-P Bossi, P Menis, J Lia, M Fortpied, C Liu, Y Lhommel, R Lemort, M Schmitz, S Canevari, S De Cecco, L Guzzo, M Bianchi, R Quattrone, P Crippa, F Duprez, T Lalami, Y Quiriny, M de Saint Aubain, N Clement, P M Coropciuc, R Hauben, E Licitra, L F Producer: 20191125 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	324.	therascreen® EGFR RGQ PCR Kit: A Companion Diagnostic for Afatinib and Gefitinib in Non-Small Cell Lung Cancer. [electronic resource] by Syed, Yahiya Y Producer: 20161213 In: Molecular diagnosis & therapy vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	325.	EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma. [electronic resource] by He, Mai Capelletti, Marzia Nafa, Khedoudja Yun, Cai-Hong Arcila, Maria E Miller, Vincent A Ginsberg, Michelle S Zhao, Binsheng Kris, Mark G Eck, Michael J Jänne, Pasi A Ladanyi, Marc Oxnard, Geoffrey R Producer: 20120628 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	326.	[A new perspective in the treatment of non-small-cell lung cancer (NSCLC). Role of afatinib: An oral and irreversible ErbB family blocker]. [electronic resource] by Wislez, Marie Malka, David Bennouna, Jaafar Mortier, Laurent Bensadoun, René-Jean Sicard, Jérôme Dielenseger, Pascale Rey, Jean-Baptiste Moro-Sibilot, Denis Scotté, Florian Producer: 20140822 In: Bulletin du cancer vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	327.	Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation. [electronic resource] by Tanizaki, Junko Banno, Eri Togashi, Yosuke Hayashi, Hidetoshi Sakai, Kazuko Takeda, Masayuki Kaneda, Hiroyasu Nishio, Kazuto Nakagawa, Kazuhiko Producer: 20171030 In: Lung cancer (Amsterdam, Netherlands) vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	328.	An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib. [electronic resource] by Sato, Mitsuo Matsui, Akira Shimoyama, Yoshie Omote, Norihito Morise, Masahiro Hase, Tetsunari Tanaka, Ichidai Suzuki, Kojiro Hasegawa, Yoshinori Producer: 20190222 In: Internal medicine (Tokyo, Japan) vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	329.	Afatinib Achieved Remarkable Disease Control in a Chinese Patient With Lung Adenocarcinoma Harboring Rare EGFR Exon 18-25 Kinase Domain Duplication. [electronic resource] by Wang, Xiao-Fei Zhao, Qi-Tao Chen, Cheng Producer: 20210714 In: American journal of therapeutics vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	330.	Common EGFR-mutated subgroups (Del19/L858R) in advanced non-small-cell lung cancer: chasing better outcomes with tyrosine kinase inhibitors. [electronic resource] by Reguart, Noemi Remon, Jordi Producer: 20160216 In: Future oncology (London, England) vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	331.	Dual human epidermal growth factor receptor 2 blockade: another step forward in treating patients with human epidermal growth factor receptor 2-positive breast cancer. [electronic resource] by Zardavas, Dimitrios Bozovic-Spasojevic, Ivana de Azambuja, Evandro Producer: 20130328 In: Current opinion in oncology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	332.	EGFR exon 18 delE709_T710insD mutated stage IV lung adenocarcinoma with response to afatinib. [electronic resource] by Ibrahim, Uroosa Saqib, Amina Atallah, Jean Paul Producer: 20180326 In: Lung cancer (Amsterdam, Netherlands) vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	333.	Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study). [electronic resource] by Akamatsu, Hiroaki Koh, Yasuhiro Okamoto, Isamu Fujimoto, Daichi Bessho, Akihiro Azuma, Koichi Morita, Satoshi Yamamoto, Nobuyuki Nakagawa, Kazuhiko Producer: 20200226 In: Lung cancer (Amsterdam, Netherlands) vol. 131 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	334.	A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404. [electronic resource] by Ninomiya, Takashi Nogami, Naoyuki Kozuki, Toshiyuki Harada, Daijiro Kubo, Toshio Ohashi, Kadoaki Kuyama, Shoichi Kudo, Kenichiro Bessho, Akihiro Fukamatsu, Nobuaki Fujimoto, Nobukazu Aoe, Keisuke Shibayama, Takuo Sugimoto, Keisuke Takigawa, Nagio Hotta, Katsuyuki Kiura, Katsuyuki Producer: 20181217 In: Lung cancer (Amsterdam, Netherlands) vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	335.	A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors. [electronic resource] by Gordon, Michael S Mendelson, David S Gross, Mitchell Uttenreuther-Fischer, Martina Ould-Kaci, Mahmoud Zhao, Yihua Stopfer, Peter Agus, David B Producer: 20130924 In: Investigational new drugs vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	336.	LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both. [electronic resource] by Katakami, Nobuyuki Atagi, Shinji Goto, Koichi Hida, Toyoaki Horai, Takeshi Inoue, Akira Ichinose, Yukito Koboyashi, Kunihiko Takeda, Koji Kiura, Katsuyuki Nishio, Kazuto Seki, Yoko Ebisawa, Ryuichi Shahidi, Mehdi Yamamoto, Nobuyuki Producer: 20140505 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	337.	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients. [electronic resource] by Wu, Shang-Gin Liu, Yi-Nan Tsai, Meng-Feng Chang, Yih-Leong Yu, Chong-Jen Yang, Pan-Chyr Yang, James Chih-Hsin Wen, Yueh-Feng Shih, Jin-Yuan Producer: 20171219 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	338.	Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). [electronic resource] by Dziadziuszko, Rafal Smit, Egbert F Dafni, Urania Wolf, Juergen Wasąg, Bartosz Biernat, Wojciech Finn, Stephen P Kammler, Roswitha Tsourti, Zoi Rabaglio, Manuela Ruepp, Barbara Roschitzki-Voser, Heidi Stahel, Rolf A Felip, Enriqueta Peters, Solange Producer: 20200721 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	339.	Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells. [electronic resource] by Ioannou, N Dalgleish, A G Seddon, A M Mackintosh, D Guertler, U Solca, F Modjtahedi, H Producer: 20111220 In: British journal of cancer vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	340.	A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab. [electronic resource] by Lin, Nancy U Winer, Eric P Wheatley, Duncan Carey, Lisa A Houston, Stephen Mendelson, David Munster, Pamela Frakes, Laurie Kelly, Steve Garcia, Agustin A Cleator, Susan Uttenreuther-Fischer, Martina Jones, Hilary Wind, Sven Vinisko, Richard Hickish, Tamas Producer: 20121106 In: Breast cancer research and treatment vol. 133 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 719 results.